Poor
Not Aligned
Patient Risk:
Moderate
Summary
Only the mechanism-related claims are supported by the provided label excerpts (HMG-CoA reductase inhibition and reduced cholesterol synthesis). Multiple other claims (avocado/food interactions, plaque/heart disease risk reduction, widely prescribed, patent expiration date, and specific food interaction examples) are not supported by the provided label sections.
Category Scores
Accurate Statements
Lipitor is an HMG-CoA reductase inhibitor that works by blocking the production of cholesterol in the liver.
Supported by Label Section 12.1 (selective competitive inhibition of HMG-CoA reductase; inhibiting cholesterol synthesis in the liver).
Lipitor is a statin medication used to lower cholesterol levels in the blood.
Partially supported by Label Section 12.1 (LIPITOR lowers plasma cholesterol and lipoprotein levels), though the excerpt does not explicitly use the term "statin" or the exact wording "lower cholesterol levels in the blood."
Unsupported Statements
Lipitor helps prevent plaque formation in arteries and reduces the risk of heart disease.
Not supported by the provided excerpts. Section 1 and Section 12.1 discuss risk factors/atherosclerosis association, but the specific claim of preventing plaque formation and reducing heart disease risk is not stated.
Avocados are listed as a food that may interact with Lipitor in the Lipitor prescribing information.
No avocado or food-interaction information is present in the provided label sections.
The exact mechanism of the Lipitor-avocado interaction is not well understood.
No avocado interaction is described in the provided excerpts, so mechanism uncertainty is unsupported.
Phytosterols in avocados can interfere with the absorption of cholesterol-lowering medications, including statins like Lipitor.
No provided label excerpt mentions phytosterols, avocados, or absorption interference.
Consuming large amounts of avocados may reduce the effectiveness of Lipitor.
No provided label excerpt addresses avocados or quantity-related effects on effectiveness.
More research is needed to fully understand the impact of avocados on Lipitor absorption.
No provided label excerpt discusses research needs regarding avocados and absorption.
The medication Lipitor is a widely prescribed medication.
No provided label excerpt contains information about prescribing frequency.
Lipitor patent expiration date is stated as 2011.
No provided label excerpt includes patent information or expiration dates.
Other foods that may interact with Lipitor include grapefruit, pomegranate, and red wine.
The provided interaction section discusses certain concurrent drugs (e.g., strong CYP3A4 inhibitors) but does not mention grapefruit, pomegranate, or red wine.
Symptoms of an interaction between Lipitor and avocados are unclear.
No provided label excerpt describes an avocado interaction or symptoms.
An interaction between Lipitor and avocados may include reduced effectiveness of the medication.
No provided label excerpt indicates avocados would reduce Lipitor effectiveness.
Contradictions
Important Omissions
Any label-supported dosing/administration details (e.g., dose adjustments, specific administration instructions).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Several claims about food interactions and reduced effectiveness due to avocados (and other foods) are not supported by the provided label excerpts, which could mislead interpretation of label-supported interaction risk.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Multiple key claims are not supported by the provided FDA label excerpts, especially the avocado and other food interaction assertions and plaque/heart disease risk reduction wording.
Suggested Improvement
Limit claims to label-supported statements from the provided excerpts (HMG-CoA reductase inhibition and lowering of plasma cholesterol/lipoproteins; risk-factor/atherosclerosis context from Section 1/12.1). Remove or qualify all avocado/personalized food-interaction, mechanism-unknown, effectiveness-reduction-by-quantity, widely prescribed, and patent date claims unless corresponding label text is provided.